Title: Staphylococcus saprophyticus - microbewiki
Headings: Staphylococcus saprophyticus
Staphylococcus saprophyticus
Contents
Classification
Higher order taxa
Species
Description and significance
Genome structure
Cell structure and metabolism
Ecology
Pathology
Application to Biotechnology
Current Research
References

Content: 3]
Recent research has shown that S. saprophyticus is an opportunistic infection. [ 10]
Application to Biotechnology
There seem to be no positive uses for Staphylococcus saprophyticus as it is a pathogen. Current Research
Some of the recent research on Staphylcoccus saprophyticus: “Urinary Bactericidal Activity of Extended-Release Ciprofloxacin (1,000 Milligrams) versus Levofloxacin (500 Milligrams) in Healthy Volunteers Receiving a Single Oral Dose” [8]
Flouroquinolones are the drug of choice for treating UTIs, but their effectiveness is affected by urine pH and contents. Research was done on 2 drugs from German pharmaceutical companies. An extended-release drug, Ciprofloxacin and another drug Levofloxacin were tested. Levoflaxacin was shown to be more effective than Ciprofoxacin against S. saprophyticus. This was a lab study and not a clinical study. Only 12 volunteers were used. “The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity” [9]
The ability to resist the attacks of lysozymes allows microbes to infect and colonize more effectively.